Submit a utility to the registry.

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Download these results as a CSV
Viewing 41 - 44 of 44 results
← Previous results
Title   Year(s) of data collection   Valuation Method   Country   Condition  
Selection of oncology health state utilities (Clavo B et al., Int J Environ Res Public Health. 2023. doi:10.3390/ijerph20021479) 2019 - 2022 EQ-5D-5L Spain Symptomatic Cancer Survivor
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
26 patients with persistent or refractory side effects of cancer treatments to investigate the effects of ozone treatment
Title
Selection of orthopedic and musculoskeletal health state utilities (Hustedt JW et al., J Hand Surg Am. 2023. doi:10.1016/j.jhsa.2022.11.021)
Year(s) of data collection
2020 - 2021
Valuation Method
EQ-5D
Country
United States of America
Condition
Thumb carpometacarpal arthritis
DOI
10.7910/DVN/VR4XYO
Author(s)
Registry, Utilities
Description
Health state utilities for orthopedic and musculoskeletal conditions
Sample Characteristics
A prospective clinical trial of 48 participants comparing denervation with suspension arthroplasty for treatment of carpometacarpal arthritis of the thumb
Title
Selection of autoimmune disease health state utilities (Armuzzi A et al., BMC Gastroenterol. 2023. doi:10.1186/s12876-023-02640-7)
Year(s) of data collection
2020 - 2021
Valuation Method
EQ-5D-5L
Country
France, Germany, Italy, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America
Condition
Ulcerative colitis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
a point-in-time survey of 164 matched patients treated with tofacitinib
Title
Selection of autoimmune disease health state utilities (Schreiber S et al., J Crohns Colitis. 2023. doi:10.1093/ecco-jcc/jjad018)
Year(s) of data collection
2017 - 2018
Valuation Method
EQ-5D
Country
Argentina, Australia, Belgium, Bulgaria, Canada, Croatia, Czechia, France, Georgia, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea (Republic of), Malaysia, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan (Province of China), Ukraine, United Kingdom of Great Britain and Northern Ireland, United States of America
Condition
Ulcerative colitis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
An RCT for filgotinib in 786 adults with moderately to severely active UC
← Previous results